1 served, "the bile never enters the stomach in a natural state and when it does it produces a contrary effect viz a nausea."' William Beaumont2 in 1833 noted similar clinical findings in Alexis St. Martin. On the other hand, Da Costa in 1925 stated that "After every gastroenterostomy some bile enters the stomach. It does no harm, and its alkalinity antagonizes any tendency to recurrence of ulceration."3 Over the years there has been a growing awareness of the significance of duodenogastric reflux. Schindler4 in 1947 noted bile stained gastric fluid consistently in patients with gastric ulcer while performing endoscopy. In 1963 duPlessis56 was convinced that bile reflux caused gastritis, that it was progessive from the antrum to the fundus, and that gastric ulcer occurred in a bed of gastritis, usually of the atrophic type. Lawson7 demonstrated these findings experimentally in 1964 and showed the protective effect of Roux-Y diversion of the duodenal contents downstream. Capper8 observed duodenogastric reflux using Barium studies and Rhodes showed bile reflux using C14 labelling of the bile pool. The association of bile in the gastric aspirate was apparent in patients with gastric ulcer and Davenport9 in 1968 identified gastric mucosal damage due to bile and documented H+ back diffusion through the mucosal surface.
Silen'°in 1971 recognized bile reflux to be destructive to the gastric mucosa in an article entitled, "Malevolent Gall." Several3' 1-24 investigators in a series of experimental and clinical studies demonstrated conclusively that bile, in an acid medium, is injurious to the gastric mucosa, especially in the presence of ischemia, and that bile plus pancreatic juice and duodenal secretions containing lysolecithin produced the greatest damage to the gastric mucosa. Meshkinpour25 noted a higher concentration of bile acids in gastric ulcer patients who also had a heavy growth of aerobic and anaerobic Gram negative bacilli in the gastric and intestinal aspirates. Gadacz and Zuidema26 identified deoxycholic acid in higher concentrations in symptomatic patients. Fisher and Cohen27 found pyloric sphincter dysfunction in patients with gastric ulcer and concluded that duodenogastric reflux through an incompetent sphincter allowed the bile to pool in the stomach, causing back diffusion of H+, release of histamine, stimulation of pepsinogen, disruption of the mucosa, and auto digestion to form gastric ulcers.
In clinical studies, the largest series has concerned the patients with enterogastric reflux following gastric surgery (i.e., Billroth I and II, pyloroplasty, and gastroenterostomy, Billroth II being the greatest offender). In 1969 van Heerden28 presented six patients with postoperative "Alkaline Reflux Gastritis" documented with endoscopic findings and corrected by Roux-Y gastrojejunostomy. This report was followed by more extensive series by Drapanas and Bethea,29 Herrington and Sawyers,30 Boren  and Way,3' Kennedy and Green,32 Fiore and Jesseph,33  Eckstam and Scudamore,34 and Bushkin and Woodward,35 all of whom agreed on the need for diversion of enteric contents away from the stomach, Roux-Y anastomosis being the preferred method. Woodward clearly defined the clinical findings of alkaline bile reflux gastritis as opposed to afferent loop syndrome which had been the generic term for postgastrectomy epigastric pain with bilious vomiting. DuPlessis, 6 Drapanas, 29 and Woodward36 recognized,the inevitable consequences of enterogastric reflux in susceptible patients and recommended Roux-Y diversion as the primary operation for ulcer. Since it was shown to be effective in treating the disease, they reasoned that it would be equally effective in avoiding the disease. All authors agree that to be effective the operation should include three elements: truncal vagotomy, antrectomy, and Roux-Y anastomosis 45-60 cm in length. In recent years enterogastric reflux has been observed in the nonoperated patients and with increasing frequency in patients with gallstones, past or present. An experience with 42 patients with the spontaneous form of this disease is the subject of this paper.
Materials and Methods
All 42 patients had the spontaneous or nonoperative form of the disease and had the following criteria: Results Upper GI series was positive for ulcer or obstruction in four of 42 patients (10%). There were no findings to suggest the etiology. In the patients requiring antrectomy and Roux-Y anastomosis, 10 of 12 patients (83%) had biliary disease, seven previous and three current. Esophagogastroduodenoscopy revealed esophagitis and gastritis in the presence of a bile pool in the stomach in all patients. The bile pool varied from 30-300 cc (average 90 cc).
Discussion
Esophagogastroduodenoscopy has provided the essential tool to determine the presence of enterogastric reflux gastritis and esophagitis. By endoscopic identification of a bile pool and, once aspirated, the recognition of gastritis and esophagitis confirmed by endoscopic biopsy, we now have a way of making the diagnosis. A patient with constant burning epigastric pain, a bile pool, gastritis-esophagitis, and hypochlorhydria has all the elements necessary for the diagnosis. The upper GI series will miss most patients with this diagnosis until the endstage with ulcer, bezoars, hemorrhage, or obstruction. The barium study can neither determine the mechanism of injury nor provide a histologic specimen. We have therefore a subset of patients with dyspepsia, heartburn, and regurgitation who in the early and middle stage will have a normal upper GI series, who will not respond to the usual measures of antacids, bland diet, possible cimetidine or metoclopramide, and remain undiagnosed while they are tried on tranquilizers and sedatives. By adding two studies, gastric analysis and gastroscopy, at this point a correct diagnosis can be made and medical treatment with metoclopramide has proved helpful in most patients, especially before ulcer, hemorrhage, and obstruction occur.
It is interesting to note the high incidence of biliary disease past and present in patients with the spontaneous form of the disease and also the high incidence in women (Fig. 1) . Twenty-five of the 42 
food leaving the stomach, mixing with the bile pancreatic and duodenal secretions, and all being swept downstream in the normal fashion. Two hours after a meal and especially during extended periods of fast, e.g., during sleep, the bile pools in the duodenum, most going downstream and some refluxing backward through the pylorus into the antrum. In time, the presence of the biliary pancreatic duodenal secretions in the stomach produces such an irritant effect that back diffusion of H+ occurs, gastritis is produced, and the process recurs endlessly until significant gastritis and esophagitis result.
Among the patients with gallstones, Johnson38 describes a group without biliary colic whose main complaints, i.e., postprandial fullness, early satiety, bitter regurgitation, and heartburn, are a reflection of impaired gastric emptying. Fisher27 and Cohen studied patients with bile reflux gastritis and identified pyloric sphincter dysfunction, producing bile reflux into the stomach with the progressive changes previously described leading to gastritis and eventually to gastric ulcer. It is entirely possible that such patients may have asymptomatic gallstones with a primary antral-pyloric-duodenal dysfunction causing reflux of duodenal contents as their underlying problem. Johnson38 found that 30% of patients with gallstones who had biliary dyspepsia but no colic were not improved following cholecystectomy since the operation did not prevent the duodenogastric reflux. It is in such patients that metoclopramide has been found effective since it coordinates the sequestial contractions of the antrum, pylorus, and duodenum and has provided relief for this truly functional disease.
It is interesting to note that four of 42 patients in this series had serum gastrins over 1000 picrograms/cc and all had hypochlorhydria. agus has been anastomosed to the jejunum, end-to-side, there will be reflux esophagitis in 100% of patients and only a Roux-Y type of operation can correct this process.
Payne' at the Mayo Clinic also has reported bile reflux esophagitis following total gastrectomy if an esophagoduodenal anastomosis has been used. Here too a Roux-Y anastomosis has been found curative.
The presence of anemia in 24% of the total group and in 50% of the operative group reflects the advanced stage of the disease at the time of diagnosis. One patient in the nonoperative group was aged 82, had dyspepsia, a hemoglobin of 8.9, BAO 0.3 mEq/l, and had been given antacids and bland diet by her family physician. By endoscopy, however, a bile pool was seen, esophagitis and chronic atrophic gastritis were proved histologically, and she has responded dramatically to metoclopramide, B 12, and a balanced diet. She is now asymptomatic and her hemoglobin has risen to 12 gms/dl after 3 months of treatment.
The pathologic changes vary from mild to severe and the precise definition requires histologic evidence. In the more advanced stage e.g., the 12 patients in the surgical group, three had ulcers, four had dysplasia, five had intestinal metaplasia, and six had chronic atrophic gas- The gastric analysis is essential to determine the level of acid in the gastric aspirate. The tube must be placed in the antrum fluoroscopically to achieve reliable results.
In the surgical procedure, all patients had an antrectomy with Roux-en-Y gastrojejunostomy at 45-60 cm and, in addition, six biliary procedures and four Nissen repairs were added (Table 4 ). In general a vagotomy is included whenever any form of gastric resection is performed, but in some circumstances it is not pursued (e.g., in patients with very low BAO, less than 1.5) in patients who have had a previous Nissen fundoplication or in the elderly poor risk patient in whom the dissection responded to esophagogastrojejunoscopy with release of the adhesive bands. 4' Considering the fact that 42 of 60 patients (70%) had the spontaneous form of enterogastric reflux gastritis and esophagitis, it is essential that a correct diagnosis be made so that metoclopramide can be given early and hopefully avoid progression of the disease. In contrast, the patients who develop the disease post-Billroth II have nothing to gain from metaclopramide, since the fundus does not have effective peristalsis and it drains by gravity.
The medical treatment seems to be effective in the 26 patients in this series followed for the year that metoclopramide has been available clinically but the follow-up has been too short to be conclusive. It is important to remember that nervousness, agitation, and occasionally pseudotetanus may occur but intramuscular Diphenhydramine HCI provides prompt and effective relief. One patient had discontinued medication and another is on reduced dosage.
Summary
An experience with 42 patients with enterogastric reflux gastritis and esophagitis is presented. Only 12 of the 42 patients required surgery to divert the biliarypancreatic duodenal secretions downstream 45-60 cm. In the surgical group 90% were women, 90% had hypocholorhydria, 83% had biliary disease, current or remote, and 50% had anemia. Nine of the 12 surgical patients had an excellent response, two a good response, and one was lost to follow-up. Two years ago, the first effective oral medication, metoclopramide, became available for clinical use and the results have been favorable in 28 patients but the follow-up is short and there are some undesirable side-effects.
The essence of the diagnosis is endoscopic demonstration of a bile pool, endoscopic biopsy proof of gastritis and esophagitis, in patients with hypochlorhydria who have a constant burning epigastric pain, with heartburn and bilious regurgitation.
Patients with end-stage disease (i.e., hemorrhage, severe gastritis and esophagitis, ulcers of the esophagus and stomach, obstruction due to antral fibrosis, and stricture of the esophagus) cannot respond to medical treatment but do well with vagotomy antrectomy and Roux-en-Y gastrojejunostomy 45-60 cm long.
Since medical treatment in patients with mild to moderate enterogastric reflux gastritis is now available, it is essential that objective findings with esophagogastroduodenoscopy with biopsy and also gastric analysis be obtained. The random use of diet, antacids, cimetidine, sucralfate, and metoclopramide in patients with dyspepsia can lead only to poor response and further 174 Although the most common indication for surgery was intractability, the most pressing indication was pyloric obstruction due to antral fibrosis or prepyloric ulcers in four of the 12 patients. Anemia was noted in five patients and two of them had recurrent hematemesis. The high incidence of synchronous biliary disease in association with enterogastric reflux gastritis and esophagitis is well-known. Cholecystectomy was necessary in three patients and in three others transduodenal sphincteroplasty was performed, one with choledocholithotomy. A Nissen repair was performed in four patients and an Angelchick prosthesis was removed in one of them since it was too low and had produced obstruction. All 12 patients had intractability, but in only two out of 12 patients was intractability the only indication. Histologically there were four patients with chronic atrophic gastritis, two with intestinal metaplasia, one with dysplasia, and one with Barretts esophagus, all of which are premalignant lesions.
The surgical results in the 12 patients were encouraging (Table 5 ). The antrectomy with Roux-Y was performed 1-8 years ago, average 3 years, and 11 of the 12 patients had a good to excellent response (nine were excellent) and one patient was lost to follow-up. There was neither mortality nor reoperation, but two patients had partial small bowel obstruction due to adhesions and they have Antrectomy with Roux-Y 12 patients Excellent (9) Good (2) Lost to follow-up (1) progression of the disease. Properly identified patients with this disease can respond well to metoclopramide and avoid the relentless progression to end-stage disease requiring surgical intervention. Esophagogastroduodenoscopy with biopsy is the sine qua non in the diagnosis of enterogastric reflux gastritis.
